Clinical trials
Observational Esophageal Atresia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 5 |
| Unknown status | 5 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Lille | 3 |
| Arlyne Thung | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Boston Children's Hospital | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Cook Research Incorporated | 1 |
| Guangzhou Women and Children's Medical Center | 1 |
| Hacettepe University | 1 |
| Hospital El Cruce | 1 |
| King's College London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Atresia | 19 |
| Hernias, Diaphragmatic, Congenital | 3 |
| Gastroschisis | 2 |
| Hernia, Umbilical | 2 |
| Omphalocele | 2 |
| Tracheoesophageal Fistula | 2 |
| Anorectal Malformations | 1 |
| Asthma | 1 |
| Bronchial Hyperreactivity | 1 |
| Critical Illness | 1 |
Trials
Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.